Daniel A. Ermann, MD

@ErmannMD

Lymphoma/CLL Specialist @UofUHealth @huntsmancancer | My opinions are my own |

Salt Lake City, UT Joined August 2018

435 Following 214 Followers 121 Posts

Latest posts 5

Daniel A. Ermann, MD @ErmannMD Feb 12

Had an incredible time filming and participating in this fun discussion with some amazing CLL docs. Check it out!

OncLive.com Verified account @OncLive Feb 12

How is the CLL treatment landscape shifting? Join experts to explore BTK and BCL2 inhibitor sequencing, MRD-guided strategies, and the role of pirtobrutinib.

Watch the full series: hubs.li/Q042LWcl0

@ErmannMD @UofUHealth @huntsmancancer @JavierPinillaMD @MoffittNews @mshadman @fredhutch

View quoted post on X

Daniel A. Ermann, MD @ErmannMD May 13, 2023

Fantastic article from @ChristineRyanMD discussing practical approach to Richters transformation.

Excellent overview for this truly challenging complication for our CLL/SLL patients.

Highly recommended!

Toby A. Eyre @tobyeyre82 May 13, 2023

Excellent overview by @DrMDavids + @ChristineRyanMD in #ASCO Ed Book

Well worth a read! #lymsm #CLL #RT

Practical Management of Richter Transformation in 2023 and Beyond ascopubs.org/doi/10.1200/ED…
View quoted post on X

Daniel A. Ermann, MD @ErmannMD May 1, 2023

Congratulations! So lucky and inspired to work with such an exceptional, dedicated, and patient centered clinician as @DebbieMStephens. This award is very well deserved! @huntsmancancer @lymphoma

University of Utah Department of Internal Medicine @UofUInternalMed May 1, 2023

Congratulations Dr. Stephens on receiving your NIH/NCI R50 award! This award aids exceptional clinician-scientists in NCI trial networks to promote their autonomy and growth. #medicalresearch #uofuhealth #MedicineElevated

View quoted post on X

Daniel A. Ermann, MD @ErmannMD Apr 14, 2023

Looking forward to a great conference!

Binaytara Verified account @binaytara Apr 14, 2023

Introducing Multiple Myeloma & Lymphoma faculty, @ErmannMD of @huntsmancancer! Dr. Ermann will present "Updates in the management of patients with MCL in frontline and relapsed/refractory setting." REGISTER: education.binayfoundation.org/content/multip…
@MyelomaSLC @hrshah1 #BTFMML #CME

View quoted post on X

Daniel A. Ermann, MD @ErmannMD Apr 2, 2023

Thrilled to have been invited to #DAVAWhistler and to share our data. Such a great experience and met so many amazing people @DAVAOnc

Kathryn Gallaway, MD @KE_Gallaway Apr 2, 2023

Kicking off our junior faculty session, @ErmannMD from @huntsmancancer discusses treatment and overall survival in patients with B-PLL. #DAVAWhistler

View quoted post on X